|
|
Article: Isis Pharmaceuticals' GeneTrove Division Introduces Human Gene Function Database.
- Article from:
- PR Newswire
- Article date:
- August 9, 2001
CopyrightCOPYRIGHT 2001 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Only Antisense Technology-based Database That Will Contain Information on
10,000 Human Genes to Broadly Enhance and Expedite Industry's Drug Discovery
Efforts
CARLSBAD, Calif., Aug. 9 /PRNewswire/ --
Isis Pharmaceuticals, Inc. (Nasdaq: ISIP) announced today that its GeneTrove(TM) division has introduced the antisense technology-based Human Gene Function Database, the first database that will contain information on the selective inhibition of 10,000 human genes. The breadth of GeneTrove's information-rich database will enable industry partners to efficiently identify which genes are critical in human disease and represent attractive ...